Financial Ratios

VISTA PHARMACEUTICALS LTD.

NSE : NABSE : 524711ISIN CODE : INE427C01021Industry : Pharmaceuticals & DrugsHouse : Private
BSE14.000.22 (+1.6 %)
PREV CLOSE ( ) 13.78
OPEN PRICE ( ) 14.46
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 21603
TODAY'S LOW / HIGH ( )13.61 14.46
52 WK LOW / HIGH ( ) 7.9519.7
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-1.51-0.24-0.55-1.210.31
   CEPS(Rs)-1.34-0.07-0.35-0.770.76
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)8.139.648.939.7610.97
   Tax Rate(%)3.6566.0547.306.5818.12
Margin Ratios
   Core EBITDA Margin(%)-442.82-321.16-136.58-21.083.98
   EBIT Margin(%)-464.56-435.33-178.65-10.539.08
   Pre Tax Margin(%)-585.46-663.36-300.96-17.293.69
   PAT Margin (%)-564.11-225.19-158.61-16.163.02
   Cash Profit Margin (%)-502.58-69.03-101.15-10.247.41
Performance Ratios
   ROA(%)-10.73-1.70-3.89-7.111.78
   ROE(%)-17.16-2.60-6.43-11.683.15
   ROCE(%)-9.85-3.75-5.10-5.206.28
   Asset Turnover(x)0.020.010.020.440.59
   Sales/Fixed Asset(x)0.040.020.050.911.40
   Working Capital/Sales(x)0.100.040.214.322.49
Efficiency Ratios
   Fixed Capital/Sales(x)26.1565.2020.311.100.71
   Receivable days3948.365842.771794.10149.36112.81
   Inventory Days3091.848791.542790.39167.81130.14
   Payable days849.735212.952566.2782.74103.28
Valuation Parameters
   PER(x)0.000.000.000.0065.15
   PCE(x)-6.22-124.54-25.97-6.9026.56
   Price/Book(x)1.030.961.010.541.84
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)41.00117.6034.611.382.30
   EV/Core EBITDA(x)-10.17-42.12-28.56-29.8517.08
   EV/EBIT(x)-8.83-27.01-19.37-13.0825.34
   EV/CE(x)0.770.890.830.621.36
   M Cap / Sales31.2885.9726.260.711.97
Growth Ratio
   Net Sales Growth(%)154.36-68.84-94.44-26.767.45
   Core EBITDA Growth(%)-267.2128.22-46.22-125.08-27.06
   EBIT Growth(%)-171.4424.075.57-184.93-35.91
   PAT Growth(%)-537.1855.7645.37-491.48-57.04
   EPS Growth(%)-524.2755.7654.92-491.53-58.77
Financial Stability Ratios
   Total Debt/Equity(x)0.330.350.330.520.34
   Current Ratio(x)1.691.861.651.332.14
   Quick Ratio(x)1.141.130.600.721.11
   Interest Cover(x)-3.84-1.91-1.46-1.561.69
   Total Debt/Mcap(x)0.320.370.320.960.18

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.